EBIT at other companies
Other financials
Where this comes from
Calculated from Lifecore Biomedical, Inc.’s reported figures.
Plus components not separately reported this period.
The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lifecore Biomedical, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lifecore Biomedical, Inc.'s EBIT?
- Lifecore Biomedical, Inc. (LFCR) reported EBIT of -$4.67M in Q1 2026.
- How has Lifecore Biomedical, Inc.'s EBIT changed year-over-year?
- Lifecore Biomedical, Inc.'s EBIT decreased by 319.4% year-over-year, from -$1.11M to -$4.67M.
- What is the long-term trend for Lifecore Biomedical, Inc.'s EBIT?
- Over 2 years (2022 to 2025), Lifecore Biomedical, Inc.'s EBIT has grown at a 36.7% compound annual growth rate (CAGR), from -$12.68M to -$23.69M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.